New measures in response to Covid-19 scrutinised
The Committee’s session will explore the current understanding and analysis of the Omicron variant of SARS-CoV-2. Topics will include:
- updates on the latest understanding of Omicron
- vaccines
- the latest experience of South Africa
- non-pharmaceutical interventions (NPIs)
Meeting details
At 9:30am: Oral evidence
Inquiry
UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Former Chair at UK Vaccine Taskforce
At 10:00am: Oral evidence
Inquiry
UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Chair at South African Medical Association
At 10:30am: Oral evidence
Inquiry
UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Chair, COVID-19 panel at Joint Committee on Vaccination and Immunisation
At 11:00am: Oral evidence
Inquiry
UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Chief Medical Officer at Moderna
At 11:30am: Oral evidence
Inquiry
UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Chief Medical Adviser at UK Health Security Agency
Director General for Data, Analytics and Surveillance at UK Health Security Agency